Literature DB >> 15022159

Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans.

Sárka Chlopcíková1, Jitka Psotová, Petra Miketová, Vilím Simánek.   

Abstract

Silymarin, an extract of fl avonolignans from the dried fruits of milk thistle (Silybum marianum L. Gaertneri) and its constituents silibinin, dehydrosilibinin, silychristin and silydianin were tested for protective effects on rat cardiomyocytes exposed to doxorubicin. Silymarin and individual fl avonolignans did not exert cytotoxicity in the range 25-100 micro m (incubation 9 h). Dehydrosilibinin was tested only at 25 micro m concentration due to its low solubility. All substances increased the cell ATP level. Silymarin and fl avonolignans displayed a dose-dependent cytoprotection against doxorubicin (100 micro m, incubation 8 h). The protective effects of silymarin, silibinin, dehydrosilibinin and silychristin were comparable to that of dexrasoxane, while silydianin exerted the best protective effect. The ability of silymarin complex and its components to protect cardiomyocytes against doxorubicin-induced oxidative stress is due mainly to their cell membrane stabilization effect, radical scavenging and iron chelating potency. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15022159     DOI: 10.1002/ptr.1415

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  10 in total

Review 1.  Silymarin and epithelial cancer chemoprevention: how close we are to bedside?

Authors:  Manjinder Kaur; Rajesh Agarwal
Journal:  Toxicol Appl Pharmacol       Date:  2006-11-15       Impact factor: 4.219

Review 2.  A Comprehensive Review of the Cardiovascular Protective Properties of Silibinin/Silymarin: A New Kid on the Block.

Authors:  Nikolaos P E Kadoglou; Chrystalla Panayiotou; Michail Vardas; Nikolaos Balaskas; Nikolaos G Kostomitsopoulos; Alexandra K Tsaroucha; Georgia Valsami
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-27

3.  A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.

Authors:  Thomas W Flaig; Daniel L Gustafson; Lih-Jen Su; Joseph A Zirrolli; Frances Crighton; Gail S Harrison; A Scott Pierson; Rajesh Agarwal; L Michael Glodé
Journal:  Invest New Drugs       Date:  2006-11-01       Impact factor: 3.850

4.  Ultrasonic-assisted enzymatic extraction of silymarin from the Silybum marianum seed shell and evaluation of its antioxidant activity in vitro.

Authors:  Fei Zhao; XinHua Li
Journal:  EXCLI J       Date:  2015-07-27       Impact factor: 4.068

Review 5.  Protective effect of silymarin against chemical-induced cardiotoxicity.

Authors:  Bibi Marjan Razavi; Gholamreza Karimi
Journal:  Iran J Basic Med Sci       Date:  2016-09       Impact factor: 2.699

6.  Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.

Authors:  Kamran Harati; Björn Behr; Christoph Wallner; Adrien Daigeler; Tobias Hirsch; Frank Jacobsen; Marcus Renner; Ali Harati; Marcus Lehnhardt; Mustafa Becerikli
Journal:  Mol Med Rep       Date:  2016-11-28       Impact factor: 2.952

Review 7.  Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity.

Authors:  Dominique Delmas; Jianbo Xiao; Anne Vejux; Virginie Aires
Journal:  Molecules       Date:  2020-04-25       Impact factor: 4.411

8.  The protective effect of silybin against lasalocid cytotoxic exposure on chicken and rat cell lines.

Authors:  Lidia Radko; Wojciech Cybulski; Wojciech Rzeski
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

9.  Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart.

Authors:  Eva Gabrielová; Aleksey Vladimirovich Zholobenko; Lenka Bartošíková; Jiří Nečas; Martin Modriansky
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

10.  Protective Effects of Silymarin and Silibinin against DNA Damage in Human Blood Cells.

Authors:  Flávio Fernandes Veloso Borges; Carolina Ribeiro E Silva; Wanessa Moreira Goes; Fernanda Ribeiro Godoy; Fernanda Craveiro Franco; Jefferson Hollanda Véras; Elisa Flávia Luiz Cardoso Bailão; Daniela de Melo E Silva; Clever Gomes Cardoso; Aparecido Divino da Cruz; Lee Chen-Chen
Journal:  Biomed Res Int       Date:  2018-10-02       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.